Endoscopic Ultrasound-Guided Versus Transjugular Portal Pressure Measurements: Systematic Review and Meta-Analysis
Digestive Diseases and Sciences · 2026
DOI: 10.1007/s10620-026-10042-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Rintaro Hashimoto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Health Care, 200 Hawkins Dr, Iowa City, IA, 52242, U…. Hauptthemen laut MEDLINE: Portal Pressure, Endosonography, Hypertension, Portal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Published reviews of endoscopic ultrasound-guided portal pressure gradient (EUS-PPG) have emphasized feasibility and safety. We performed a systematic review and meta-analysis specifically to evaluate how closely EUS-based portal pressure measurements track invasive comparator measurements in prospective paired studies and to summarize agreement, technical success, and adverse events. METHODS: We searched major databases through January 2026 for prospective cohorts reporting same-patient EUS-based portal pressure measurement and invasive hemodynamic measurements. Correlations were pooled with random-effects models and analyzed separately for studies comparing EUS-PPG with hepatic venous pressure gradient (HVPG) and studies comparing EUS-based portal measurements with direct portal venous pressure. Agreement and threshold discordance were summarized descriptively. RESULTS: Six prospective cohorts (127 attempted procedures) were included. In studies using HVPG as the comparator, the pooled correlation was 0.82 (95% CI, 0.72-0.89; I2 = 0%). In studies comparing EUS-based portal measurements with direct portal venous pressure, the pooled correlation was 0.86 (95% CI, 0.72-0.93; I2 = 16.9%). Technical success was 95.3%. EUS-PPG-attributed adverse events occurred in 2.4% of procedures, with no procedure-related deaths. Agreement data were limited. Reported limits of agreement were wide (approximately - 6 to + 7 mmHg), and discrepancies of 5 mmHg or greater occurred in 4 of 30 paired measurements. CONCLUSIONS: EUS-based portal pressure measurement is feasible and shows a strong association with invasive hemodynamic comparators, but the evidence base remains small (six cohorts, 127 attempted procedures). Further study will be necessary to establish patient-level agreement, procedural reproducibility, EUS-specific clinically significant portal hypertension thresholds, and whether HVPG-based decision thresholds can be transferred to EUS-derived measurements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Health Care, 200 Hawkins Dr, Iowa City, IA, 52242, USA. rintaro-hashimoto@uiowa.edu.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Health Care, 200 Hawkins Dr, Iowa City, IA, 52242, USA.
- Division of Gastroenterology and Hepatology, Digestive Health Institute, Hoag Memorial Hospital Presbyterian, Hoag Health, 500 Superior Avenue, Newport Beach, CA, 92663, USA.
Zitieren
APA
Hashimoto, R., Tanaka, T., & Chang, K. J. (2026). Endoscopic Ultrasound-Guided Versus Transjugular Portal Pressure Measurements: Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-026-10042-4
Vancouver
Hashimoto R, Tanaka T, Chang KJ. Endoscopic Ultrasound-Guided Versus Transjugular Portal Pressure Measurements: Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-026-10042-4
BibTeX
@article{Hashimoto2026,
author = {Hashimoto, Rintaro and Tanaka, Tomohiro and Chang, Kenneth J},
title = {Endoscopic Ultrasound-Guided Versus Transjugular Portal Pressure Measurements: Systematic Review and Meta-Analysis},
journal = {Digestive Diseases and Sciences},
year = {2026},
doi = {10.1007/s10620-026-10042-4}
}
EUVIMED